Drugs that Target Cellular Signaling Pathways for Breast Cancer Treatment


Numerous molecular targeting agents have been created as a result of the discovery of genetic abnormalities and the investigation of various cellular signalling pathways. These agents can be used as therapeutic targets for a variety of diseases. Many new medications have been become available recently to treat breast cancer. These medications can be used orally or intravenously. These drug delivery techniques reduce toxicity and boost effectiveness. The patients have benefited in numerous ways from these new medications and delivery systems, which have replaced the more time-consuming older ones. They have fewer adverse effects and provide patients with better benefits.


Author (s) Details

Nadeem Kizilbash

Department of Chemistry, Faculty of Physical Sciences, Quaid-i-Azam University, Islamabad-45320, Pakistan.

Marjan Assefi

University of North Carolina at Greensboro, Greensboro, NC 27403, USA.

Naila Mahmood

Molecular Immunology Laboratory, Atta-ur-Rehman School of Applied Biosciences, National University of Science and Technology, Islamabad, Pakistan.

Sohila Nankali

Northcentral University, San Diego, CA, USA.

A. Nanklai

Kermanshah University of Medical Sciences, Kermanshah, Iran.

Gholamreza Abdi

Department of Biotechnology, Persian Gulf Research Institute, Bushehr, 75169, Iran.



View Book :-  https://stm.bookpi.org/CPMS-V6/article/view/7686


Keywords –  Cellular signaling, breast cancer treatment, genetic mutations

Leave A Comment